Search Results - "ЭПИТЕЛИАЛЬНО-МЕЗЕНХИМАЛЬНАЯ ТРАНСФОРМАЦИЯ"

Source: Počki, Vol 7, Iss 3, Pp 167-175 (2018)
KIDNEYS; Том 7, № 3 (2018); 167-175
Почки-Počki; Том 7, № 3 (2018); 167-175
Нирки-Počki; Том 7, № 3 (2018); 167-175

File Description: application/pdf

Access URL: http://kidneys.zaslavsky.com.ua/article/download/140200/138338
https://doaj.org/article/7084fc0a771442c38475318e209ab6e7
http://kidneys.zaslavsky.com.ua/article/download/140200/138338
http://kidneys.zaslavsky.com.ua/article/view/140200
https://www.openaccessrepository.it/record/117021
http://kidneys.zaslavsky.com.ua/article/view/140200

View record at OpenAIRE Full Text Finder

5

Academic Journal

HISTOGENETIC ASPECTS OF PNEUMOFIBROSIS DURING CONIOTIC CHANGES IN KUZBASS MINERS

Authors: Олег Иванович Бондарев, Сергей Николаевич Филимонов

Source: Медицина в Кузбассе, Vol 21, Iss 3, Pp 54-60 (2022)

Subject Terms: шахтеры, пневмокониоз, эндотелиальная дисфункция, пылевая патология легких, эпителиально-мезенхимальная трансформация, апоптоз, легочный гистион, Medicine

File Description: electronic resource

Relation: https://mednauki.ru/index.php/MK/article/view/775; https://doaj.org/toc/1819-0901; https://doaj.org/toc/2588-0411

Access URL: https://doaj.org/article/d57d2dfa6b084a3f9c06f4f94a208a95

View record in DOAJ Full Text Finder

6

Academic Journal

MORPHOFUNCTIONAL STATE OF THE ENDOTHELIAL SYSTEM IN WORKERS OF THE KUZBASS COAL INDUSTRY

Authors: Олег Иванович Бондарев, Сергей Людовикович Кан, Сергей Николаевич Филимонов

Source: Медицина в Кузбассе, Vol 21, Iss 1, Pp 25-32 (2022)

Subject Terms: шахтеры, эндотелий, эндотелиальная дисфункция, пылевая патология легких, эпителиально-мезенхимальная трансформация, иммуногистохимическое исследование, гемодинамическая система, легочный гистион, Medicine

File Description: electronic resource

Relation: https://mednauki.ru/index.php/MK/article/view/684; https://doaj.org/toc/1819-0901; https://doaj.org/toc/2588-0411

Access URL: https://doaj.org/article/1f3904e520b748bfaf637c151870b0cb

View record in DOAJ Full Text Finder

7

Academic Journal

HISTOGENETIC ASPECTS OF PNEUMOFIBROSIS DURING CONIOTIC CHANGES IN KUZBASS MINERS

Source: Медицина в Кузбассе, Vol 21, Iss 3, Pp 54-60 (2022)

Subject Terms: легочный гистион, эндотелиальная дисфункция, пылевая патология легких, апоптоз, шахтеры, пневмокониоз, Medicine, эпителиально-мезенхимальная трансформация

Access URL: https://doaj.org/article/d57d2dfa6b084a3f9c06f4f94a208a95

View record at OpenAIRE Full Text Finder

8

Academic Journal

MORPHOFUNCTIONAL STATE OF THE ENDOTHELIAL SYSTEM IN WORKERS OF THE KUZBASS COAL INDUSTRY ; МОРФОФУНКЦИОНАЛЬНОЕ СОСТОЯНИЕ СИСТЕМЫ ЭНДОТЕЛИЯ У РАБОТНИКОВ УГОЛЬНОЙ ПРОМЫШЛЕННОСТИ КУЗБАССА

Authors: Бондарев, Олег Иванович, Кан, Сергей Людовикович, Филимонов, Сергей Николаевич

Source: Medicine in Kuzbass; Том 21, № 1 (2022): март; 25-32 ; Медицина в Кузбассе; Том 21, № 1 (2022): март; 25-32 ; 2588-0411 ; 1819-0901

Subject Terms: miners, endothelium, endothelial dysfunction, pulmonary dust pathology, epithelial-mesenchymal transformation, immunohistochemical examination, hemodynamic system, pulmonary histione, шахтеры, эндотелий, эндотелиальная дисфункция, пылевая патология легких, эпителиально-мезенхимальная трансформация, иммуногистохимическое исследование, гемодинамическая система, легочный гистион

File Description: text/html; application/pdf

Relation: http://mednauki.ru/index.php/MK/article/view/684/1211; http://mednauki.ru/index.php/MK/article/view/684/1231; http://mednauki.ru/index.php/MK/article/view/684

Availability: http://mednauki.ru/index.php/MK/article/view/684

View record from BASE

9

Academic Journal

HISTOGENETIC ASPECTS OF PNEUMOFIBROSIS DURING CONIOTIC CHANGES IN KUZBASS MINERS ; ГИСТОГЕНЕТИЧЕСКИЕ АСПЕКТЫ ПНЕВМОФИБРОЗА ПРИ КОНИОТИЧЕСКИХ ИЗМЕНЕНИЯХ У ШАХТЕРОВ КУЗБАССА

Authors: Бондарев, Олег Иванович, Филимонов, Сергей Николаевич

Source: Medicine in Kuzbass; Том 21, № 3 (2022): сентябрь; 54-60 ; Медицина в Кузбассе; Том 21, № 3 (2022): сентябрь; 54-60 ; 2588-0411 ; 1819-0901

Subject Terms: miners, pneumoconiosis, endothelial dysfunction, dust pathology of the lungs, epithelial-mesenchymal transformation, apoptosis, pulmonary histione, шахтеры, пневмокониоз, эндотелиальная дисфункция, пылевая патология легких, эпителиально-мезенхимальная трансформация, апоптоз, легочный гистион

File Description: text/html; application/pdf

Relation: http://mednauki.ru/index.php/MK/article/view/775/1347; http://mednauki.ru/index.php/MK/article/view/775/1393; http://mednauki.ru/index.php/MK/article/view/775

Availability: http://mednauki.ru/index.php/MK/article/view/775

View record from BASE

10

Academic Journal

MORPHOFUNCTIONAL STATE OF THE ENDOTHELIAL SYSTEM IN WORKERS OF THE KUZBASS COAL INDUSTRY

Source: Медицина в Кузбассе, Vol 21, Iss 1, Pp 25-32 (2022)

Subject Terms: иммуногистохимическое исследование, пылевая патология легких, легочный гистион, шахтеры, Medicine, гемодинамическая система, эндотелиальная дисфункция, эндотелий, эпителиально-мезенхимальная трансформация

Access URL: https://doaj.org/article/1f3904e520b748bfaf637c151870b0cb

View record at OpenAIRE Full Text Finder

11

Academic Journal

MODERN CONCEPTS ON THE ROLE OF HYPOXIA IN THE DEVELOPMENT OF TUMOR RADIORESISTANCE ; СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ О РОЛИ ГИПОКСИИ В РАЗВИТИИ РАДИОРЕЗИСТЕНТНОСТИ ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ

Authors: M. A. Senchukova, E. V. Makarova, E. A. Kalinin, V. V. Tkachev, E. Y. Zubareva, М. А. Сеньчукова, Е. В. Макарова, Е. А. Калинин, В. В. Ткачев, Е. Ю. Зубарева

Contributors: The study was funded by Russian Foundation for Basic Research, grant No 18-415-560005 and No.19-415- 560004., Работа выполнена при финансовой поддержке РФФИ и субъекта РФ в рамках научных проектов № 18-415-560005 и 19-415-560004.

Source: Siberian journal of oncology; Том 19, № 6 (2020); 141-147 ; Сибирский онкологический журнал; Том 19, № 6 (2020); 141-147 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2020-19-6

Subject Terms: ангиогенез, radiation therapy, radioresistance, hypoxia, epithelial-mesenchymal transformation, angiogenesis, лучевая терапия, радиорезистентность, гипоксия, эпителиально-мезенхимальная трансформация

File Description: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/1653/819; Iyer N.G., Tan D.S., Tan V.K., Wang W., Hwang J., Tan N.C., Sivanandan R., Tan H.K., Lim W.T., Ang M.K., Wee J., Soo K.C., Tan E.H. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Cancer. 2015 May 15; 121(10): 1599–607. doi:10.1002/cncr.29251.; Roxburgh C.S., Weiser M.R. Selective use of radiation for locally advanced rectal cancer: one size does not fit all. Minerva Chir. 2018 Dec; 73(6): 592–600. doi:10.23736/S0026-4733.18.07791-X.; Baskar R., Itahana K. Radiation therapy and cancer control in developing countries: Can we save more lives? Int J Med Sci. 2017 Jan 1; 14(1): 13–17. doi:10.7150/ijms.17288.; Hekim N., Cetin Z., Nikitaki Z., Cort A., Saygili E.I. Radiation triggering immune response and inflammation. Cancer Lett. 2015 Nov 28; 368(2): 156–63. doi:10.1016/j.canlet.2015.04.016.; Wennerberg E., Lhuillier C., Vanpouille-Box C., Pilones K.A., García-Martínez E., Rudqvist N.P., Formenti S.C., Demaria S. Barriers to Radiation-Induced In Situ Tumor Vaccination. Front Immunol. 2017 Mar 13; 8: 229. doi:10.3389/fimmu.2017.00229.; Tsoutsou P.G., Zaman K., Martin Lluesma S., Cagnon L., Kandalaft L., Vozenin M.C. Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity. Front Oncol. 2018 Dec 12; 8: 609. doi:10.3389/fonc.2018.00609.; Rachmadi L., Siregar N.C., Kanoko M., Andrijono A., Bardosono S., Suryandari D.A., Sekarutami S.M., Hernowo B.S. Role of Cancer Stem Cell, Apoptotic Factor, DNA Repair, and Telomerase Toward Radiation Therapy Response in Stage IIIB Cervical Cancer. Oman Med J. 2019; 34(3): 224–30. doi:10.5001/omj.2019.43.; Tang L., Wei F., Wu Y., He Y., Shi L., Xiong F., Gong Z., Guo C., Li X., Deng H., Cao K., Zhou M., Xiang B., Li X., Li Y., Li G., Xiong W., Zeng Z. Role of metabolism in cancer cell radioresistance and radiosensitization methods. J Exp Clin Cancer Res. 2018 Apr 23; 37(1): 87. doi:10.1186/s13046-018-0758-7.; Васильченко Н.Г., Кутилин Д.С., Тимошкина Н.Н., Потемкин Д.С., Полуэктов С.И., Гусарева М.А., Кошелева Н.Г., Солдатова К.И., Максимов А.Ю., Кит О.И., Сидоренко Ю.С. Современные схемы лучевой терапии и биомаркеры радиорезистентности опухолевых клеток прямой кишки. Сибирский онкологический журнал. 2019; 18(6): 105–113. doi:10.21294/1814-4861-2019-18-6-105-113.; Akiyama A., Minaguchi T., Fujieda K., Hosokawa Y., Nishida K., Shikama A., Tasaka N., Sakurai M., Ochi H., Satoh T. Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma. Oncol Lett. 2019; 18(6): 5952–58. doi:10.3892/ol.2019.10940.; Chou S.Y., Yen S.L., Huang C.C., Huang E.Y. Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy. BMC Cancer. 2018 Jan 30; 18(1): 105. doi:10.1186/s12885-018-4025-2.; Duregon E., Senetta R., Pittaro A., Verdun di Cantogno L., Stella G., De Blasi P., Zorzetto M., Mantovani C., Papotti M., Cassoni P. CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype. Oncotarget. 2015 Oct 6; 6(30): 29626–36. doi:10.18632/oncotarget.4988.; Fiedler M., Weber F., Hautmann M.G., Haubner F., Reichert T.E., Klingelhöffer C., Schreml S., Meier J.K., Hartmann A., Ettl T. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma. Clin Oral Investig. 2018 Jan; 22(1): 189–200. doi:10.1007/s00784-017-2099-x.; Чернышова А.Л., Старцева Ж.А., Затолокина А.А. Оптимизация выбора адъювантной лучевой терапии у больных раком тела матки I cтадии. Сибирский онкологический журнал. 2014; (6): 54–59.; Horsman M.R., Overgaard J. The impact of hypoxia and its modification of the outcome of radiotherapy. J Radiat Res. 2016 Aug; 57 Suppl 1(Suppl 1): i90i98. doi:10.1093/jrr/rrw007.; Span P.N., Bussink J. The Role of Hypoxia and the Immune System in Tumor Radioresistance. Cancers (Basel). 2019 Oct 14; 11(10): 1555. doi:10.3390/cancers11101555.; Brown J.M., Wilson W.R. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004 Jun; 4(6): 437–47. doi:10.1038/nrc1367.; Eales K.L., Hollinshead K.E., Tennant D.A. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 2016; 5(1): e190. doi:10.1038/oncsis.2015.50.; Wang H., Jiang H., Van De Gucht M., De Ridder M. Hypoxic Radioresistance: Can ROS Be the Key to Overcome It? Cancers (Basel). 2019 Jan 18; 11(1): 112. doi:10.3390/cancers11010112.; Muz B., de la Puente P., Azab F., Azab A.K. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015 Dec 11; 3: 83–92. doi:10.2147/HP.S93413.; Rohwer N., Cramer T. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat. 2011 Jun; 14(3): 191–201. doi:10.1016/j.drup.2011.03.001.; Fu Z., Chen D., Cheng H., Wang F. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia. Med Sci Monit. 2015 Jan 27; 21: 318–25. doi:10.12659/MSM.893265.; Ebner D.K., Tinganelli W., Helm A., Bisio A., Yamada S., Kamada T., Shimokawa T., Durante M. The Immunoregulatory Potential of Particle Radiation in Cancer Therapy. Front Immunol. 2017 Feb 6; 8: 99. doi:10.3389/fimmu.2017.00099.; Menon H., Ramapriyan R., Cushman T.R., Verma V., Kim H.H., Schoenhals J.E., Atalar C., Selek U., Chun S.G., Chang J.Y., Barsoumian H.B., Nguyen Q.N., Altan M., Cortez M.A., Hahn S.M., Welsh J.W. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Front Immunol. 2019 Feb 15; 10: 193. doi:10.3389/fimmu.2019.00193.; Shevtsov M., Sato H., Multhoff G., Shibata A. Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy. Front Oncol. 2019 Mar 19; 9: 156. doi:10.3389/fonc.2019.00156.; Sethumadhavan S., Silva M., Philbrook P., Nguyen T., Hatfield S.M., Ohta A., Sitkovsky M.V. Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells. PLoS One. 2017; 12(11): e0187314. doi:10.1371/journal.pone.0187314.; Noman M.Z., Hasmim M., Lequeux A., Xiao M., Duhem C., Chouaib S., Berchem G., Janji B. Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges. Cells. 2019 Sep 14; 8(9): 1083. doi:10.3390/cells8091083.; Smolarczyk R., Cichoń T., Pilny E., Jarosz-Biej M., Poczkaj A., Kułach N., Szala S. Combination of anti-vascular agent DMXAA and HIF-1α inhibitor digoxin inhibits the growth of melanoma tumors. Sci Rep. 2018 May 9; 8(1): 7355. doi:10.1038/s41598-018-25688-y.; Vanpouille-Box C., Diamond J.M., Pilones K.A., Zavadil J., Babb J.S., Formenti S.C., Barcellos-Hoff M.H., Demaria S. TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity. Cancer Res. 2015 Jun 1; 75(11): 2232–42. doi:10.1158/0008-5472.CAN-14-3511.; Horsman M.R. Measurement of Tumor Oxygenation. Int J Radiat Oncol Biol Phys. 1998 Nov 1; 42 (4): 701–4. doi:10.1016/s0360-3016(98)00332-0.; Cao X., Rao Allu S., Jiang S., Jia M., Gunn J.R., Yao C., LaRochelle E.P., Shell J.R., Bruza P., Gladstone D.J., Jarvis L.A., Tian J., Vinogradov S.A., Pogue B.W. Tissue pO2 distributions in xenograft tumors dynamically imaged by Cherenkov-excited phosphorescence during fractionated radiation therapy. Nat Commun. 2020 Jan 29; 11(1): 573. doi:10.1038/s41467-020-14415-9.; Peerlings J., Van De Voorde L., Mitea C., Larue R., Yaromina A., Sandeleanu S., Spiegelberg L., Dubois L., Lambin P., Mottaghy F.M. Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review. Methods. 2017 Nov; 130: 51–62. doi:10.1016/j.ymeth.2017.07.002.; Harada H. Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance. J Radiat Res. 2016 Aug; 57 Suppl 1(Suppl 1): 99–105. doi:10.1093/jrr/rrw012.; Zeng L., Morinibu A., Kobayashi M., Zhu Y., Wang X., Goto Y., Yeom C.J., Zhao T., Hirota K., Shinomiya K., Itasaka S., Yoshimura M., Guo G., Hammond E.M., Hiraoka M., Harada H. Aberrant IDH3α Expression Promotes Malignant Tumor Growth by Inducing HIF-1-mediated Metabolic Reprogramming and Angiogenesis. Oncogene. 2015; 34(36): 4758–66. doi:10.1038/onc.2014.411.; Yeo C.D., Kang N., Choi S.Y., Kim B.N., Park C.K., Kim J.W., Kim Y.K., Kim S.J. The role of hypoxia on the acquisition of epithelialmesenchymal transition and cancer stemness: a possible link to epigenetic regulation. Korean J Intern Med. 2017 Jul; 32(4): 589–599. doi:10.3904/kjim.2016.302.; Kakurina G.V., Kondakova I.V., Spirina L.V., Kolegova E.S., Shashova E.E., Cheremisina O.V., Novikov V.A., Choinzonov E.L. Expression of genes encoding cell motility proteins during progression of head and neck squamous cell carcinoma. Bull Exp Biol Med. 2018; 166(2): 250–252. doi:10.1007/S10517-018-4325-1.; Liu Z.J., Semenza G.L., Zhang H.F. Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang Univ Sci B. 2015 Jan; 16(1): 32–43. doi:10.1631/jzus.B1400221.; Luo Y., Li M., Zuo X., Basourakos S.P., Zhang J., Zhao J., Han Y., Lin Y., Wang Y., Jiang Y., Lan L. βcatenin nuclear translocation induced by HIF1α overexpression leads to the radioresistance of prostate cancer. Int J Oncol. 2018 Jun; 52(6): 1827–1840. doi:10.3892/ijo.2018.4368.; Koukourakis M., Kakouratos C., Kalamida D., Bampali Z., Mavropoulou S., Sivridis E., Giatromanolaki A. Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer. Int J Radiat Biol. 2016 Jul; 92(7): 353–63. doi:10.3109/09553002.2016.1162921.; Lee S.Y., Jeong E.K., Ju M.K., Jeon H.M., Kim M.Y., Kim C.H., Park H.G., Han S.I., Kang H.S. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer. 2017 Jan 30; 16(1): 10. doi:10.1186/s12943-016-0577-4.; Rycaj K., Tang D.G. Cancer stem cells and radioresistance. International journal of radiation biology. 2014; 90: 615–21. doi:10.3109/09553002.2014.892227.; Gomez-Casal R., Bhattacharya C., Ganesh N., Bailey L., Basse P., Gibson M., Epperly M., Levina V. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelialmesenchymal transition phenotypes. Mol Cancer. 2013; 12(1): 94. doi:10.1186/1476-4598-12-94.; Barker H.E., Paget J.T., Khan A.A., Harrington K.J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015 Jul; 15(7): 409–25. doi:10.1038/nrc3958.; Hellevik T., Pettersen I., Berg V., Winberg J.O., Moe B.T., Bartnes K., Paulssen R.H., Busund L.T., Bremnes R., Chalmers A., Martinez-Zubiaurre I. Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiat Oncol. 2012 Apr 13; 7: 59. doi:10.1186/1748-717X-7-59.; Lindblom E.K., Dasu A., Toma-Dasu I. Hypoxia Induced by Vascular Damage at High Doses Could Compromise the Outcome of Radiotherapy. Anticancer Res. 2019 May; 39(5): 2337–2340. doi:10.21873/anticanres.13350.; Lindblom E., Toma-Dasu I., Dasu A.Accounting for Two Forms of Hypoxia for Predicting Tumour Control Probability in Radiotherapy: An In Silico Study. Adv Exp Med Biol. 2018; 1072: 183–87. doi:10.1007/978-3-319-91287-5_29.; Vaupel P., Mayer A. Hypoxia in Tumors: Pathogenesis-Related Classification, Characterization of Hypoxia Subtypes, and Associated Biological and Clinical Implications. Adv Exp Med Biol 2014; 812: 19–24. doi:10.1007/978-1-4939-0620-8_3.; Orel V.B., Zabolotny M.A., Orel V.E. Heterogeneity of hypoxia in solid tumours and mechanochemical reactions with oxygen nanobubbles. Med Hypotheses. 2017 May; 102: 82–86. doi:10.1016/j.mehy.2017.03.006.; Birau A., Ceausu R.A., Cimpean A.M., Gaje P., Raica M., Olariu T. Assessement of angiogenesis reveals blood vessel heterogeneity in lung carcinoma. Oncol Lett. 2012 Dec; 4(6): 1183–86. doi:10.3892/ol.2012.893.; Nagy J.A., Dvorak H.F. Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets. Clin Exp Metastasis. 2012 Oct; 29(7): 657–62. doi:10.1007/s10585-012-9500-6.; Senchukova M.A., Nikitenko N.V., Tomchuk O.N., Zaitsev N.V., Stadnikov A.A. Different types of tumor vessels in breast cancer: morphology and clinical value. Springerplus. 2015 Sep 17; 4: 512. doi:10.1186/s40064-015-1293-z.; Zhou X., Liu H., Zheng Y., Han Y., Wang T., Zhang H., Sun Q., Li Z. Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor. ACS Appl Mater Interfaces. 2020 Jan 29; 12(4): 4231–4240. doi:10.1021/acsami.9b18633.; Siemann D.W., Horsman M.R. Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacol Ther. 2015 Sep; 153: 107–24. doi:10.1016/j.pharmthera.2015.06.006.; Liu S., Wu F., Zhang Y., Qin R., Zhu N., Li Y., Wang M., Zeng Q., Xie D., Li Y., Fan J., Han Y. Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model. Cancer Control. 2020 Jan-Dec; 27(1): 1073274820922553. doi:10.1177/1073274820922553.; Janssens G.O., Rademakers S.E., Terhaard C.H., Doornaert P.A., Bijl H.P., van den Ende E., Chin A., Takes R.P., de Bree R., Hoogsteen I.J., Bussink J., Span P.N., Kaanders J.H. Improved RecurrenceFree Survival with ARCON for Anemic Patients with Laryngeal Cancer. Clinical Cancer Research. 2014; 20(5): 1345–54. doi:10.1158/1078-0432.CCR-13-1730.; Akanji M.A., Rotimi D., Adeyemi O.S. Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer. Oxid Med Cell Longev. 2019 Aug 14; 2019: 8547846. doi:10.1155/2019/8547846.; Nabors L.B., Mikkelsen T., Hegi M.E., Ye X., Batchelor T., Lesser G., Peereboom D., Rosenfeld M.R., Olsen J., Brem S., Fisher J.D., Grossman S.A.; New Approaches to Brain Tumor Therapy (NABTT) Central Nervous System Consortium. A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306). Cancer. 2012 Nov 15; 118(22): 5601–7. doi:10.1002/cncr.27585.; https://www.siboncoj.ru/jour/article/view/1653

Availability: https://www.siboncoj.ru/jour/article/view/1653
https://doi.org/10.21294/1814-4861-2020-19-6-141-147

View record from BASE

12

Report